• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟与非酒精性脂肪性肝病风险:队列研究。

Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.

机构信息

Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.

出版信息

Am J Gastroenterol. 2019 Mar;114(3):453-463. doi: 10.1038/s41395-018-0283-5.

DOI:10.1038/s41395-018-0283-5
PMID:30353055
Abstract

OBJECTIVES

The role of smoking in the development of non-alcoholic fatty liver disease (NAFLD) remains controversial. We assessed the risk of incident NAFLD according to smoking status and urinary cotinine levels.

METHODS

We performed a cohort study of 199,468 Korean adults without NAFLD at baseline who were followed annually or biennially for a median of 4.1 years. The presence of fatty liver was determined using ultrasound. NAFLD severity was assessed using NAFLD fibrosis score (NFS), a non-invasive fibrosis marker.

RESULTS

During 1,070,991 person-years of follow-up, 45,409 participants developed NAFLD. Self-reported current smoking, pack-years, and urinary cotinine level were significantly associated with increased risk for NAFLD. For men, the multivariable-adjusted hazard ratios (aHR) (95% confidence intervals (CI)) for incident NAFLD comparing 10-19.9, and ≥20 pack-years to 0 pack-years were 1.25 (1.21- 1.29), and 1.36 (1.30-1.42), respectively; for women, aHR (95% CI) for NAFLD comparing 5-9.9, and ≥10 pack-years to 0 pack-years were 1.25 (1.04-1.50), and 1.46 (1.17-1.81), respectively. Smoking pack-years were also associated with increased risk for NAFLD plus intermediate or high fibrosis score. For men, the aHR (95% CI) for NAFLD plus intermediate or high NFS comparing ≥20 pack-years to 0 pack-years was 1.29 (1.18-1.42); for women, the aHR (95% CI) comparing ≥10 pack-years to 0 pack-years was 1.75 (1.12-2.73).

CONCLUSIONS

In a large cohort of young and middle-aged men and women, current smoking, pack-years, and urinary cotinine levels were positively associated with the risk of incident NAFLD, suggesting that smoking contributes to the development of NAFLD.

摘要

目的

吸烟在非酒精性脂肪性肝病(NAFLD)发展中的作用仍存在争议。我们评估了根据吸烟状况和尿可替宁水平发生 NAFLD 的风险。

方法

我们对 199468 名基线时无 NAFLD 的韩国成年人进行了队列研究,这些人每年或每两年随访一次,中位随访时间为 4.1 年。使用超声确定脂肪肝的存在。使用非侵入性纤维化标志物 NAFLD 纤维化评分(NFS)评估 NAFLD 严重程度。

结果

在 1070991 人年的随访期间,有 45409 名参与者发生了 NAFLD。自我报告的当前吸烟、吸烟包年数和尿可替宁水平与 NAFLD 风险增加显著相关。对于男性,与 0 包年相比,10-19.9 包年和≥20 包年的多变量调整后的风险比(aHR)(95%置信区间(CI))分别为 1.25(1.21-1.29)和 1.36(1.30-1.42);对于女性,与 0 包年相比,5-9.9 包年和≥10 包年的 aHR(95%CI)分别为 1.25(1.04-1.50)和 1.46(1.17-1.81)。吸烟包年数也与 NAFLD 伴中或高度纤维化评分的风险增加相关。对于男性,与 0 包年相比,NAFLD 伴中或高度 NFS 的 aHR(95%CI)为 1.29(1.18-1.42);对于女性,与 0 包年相比,aHR(95%CI)为≥10 包年,为 1.75(1.12-2.73)。

结论

在一项针对年轻和中年男性和女性的大型队列研究中,当前吸烟、吸烟包年数和尿可替宁水平与发生 NAFLD 的风险呈正相关,表明吸烟会导致 NAFLD 的发生。

相似文献

1
Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.吸烟与非酒精性脂肪性肝病风险:队列研究。
Am J Gastroenterol. 2019 Mar;114(3):453-463. doi: 10.1038/s41395-018-0283-5.
2
Association between cotinine-verified smoking status and risk of nonalcoholic fatty liver disease.可替宁验证的吸烟状况与非酒精性脂肪性肝病风险的关联。
Liver Int. 2018 Aug;38(8):1487-1494. doi: 10.1111/liv.13701. Epub 2018 Feb 17.
3
Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.队列研究非酒精性脂肪性肝病、NAFLD 纤维化评分与韩国人群中糖尿病发病风险的关系。
Am J Gastroenterol. 2013 Dec;108(12):1861-8. doi: 10.1038/ajg.2013.349. Epub 2013 Oct 8.
4
Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.代谢健康型肥胖与非酒精性脂肪性肝病的发生发展
Am J Gastroenterol. 2016 Aug;111(8):1133-40. doi: 10.1038/ajg.2016.178. Epub 2016 May 17.
5
Sleep Duration, Sleep Quality, and the Development of Nonalcoholic Fatty Liver Disease: A Cohort Study.睡眠时间、睡眠质量与非酒精性脂肪性肝病的发生发展:一项队列研究。
Clin Transl Gastroenterol. 2021 Oct 19;12(10):e00417. doi: 10.14309/ctg.0000000000000417.
6
Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study.乙型肝炎病毒感染与非酒精性脂肪性肝病风险降低的相关性:一项队列研究。
Hepatology. 2017 Mar;65(3):828-835. doi: 10.1002/hep.28917. Epub 2016 Dec 30.
7
Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis.非酒精性脂肪性肝病与反流性食管炎风险增加相关。
Dig Dis Sci. 2017 Dec;62(12):3605-3613. doi: 10.1007/s10620-017-4805-6. Epub 2017 Oct 23.
8
Smoking, urinary cotinine levels and incidence of visual impairment.吸烟、尿可替宁水平与视力损害发生率。
Sci Rep. 2021 Jan 11;11(1):398. doi: 10.1038/s41598-020-79865-z.
9
Non-Alcoholic Fatty Liver Disease Is Strongly Associated with Smoking Status and Is Improved by Smoking Cessation in Japanese Males: A Retrospective Study.非酒精性脂肪性肝病与吸烟状况密切相关,日本男性戒烟可改善非酒精性脂肪性肝病:一项回顾性研究。
Kobe J Med Sci. 2020 Nov 17;66(3):E102-E112.
10
Long working hours and increased risks of lean non-alcoholic fatty liver disease among Korean men and women.韩国男性和女性中,长时间工作与非酒精性脂肪肝消瘦型患病风险增加有关。
Sci Rep. 2023 Jul 28;13(1):12230. doi: 10.1038/s41598-023-39154-x.

引用本文的文献

1
Screening for metabolic-associated fatty liver disease in type 2 diabetes patients using non-invasive scores and ultrasound: a cross-sectional study in Egypt.使用非侵入性评分和超声对2型糖尿病患者进行代谢相关脂肪性肝病筛查:埃及的一项横断面研究。
BMC Gastroenterol. 2025 Sep 15;25(1):639. doi: 10.1186/s12876-025-03844-9.
2
Linkage Between Hemoglobin to High Density Lipoprotein-Cholesterol Ratio and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationally Representative Study.血红蛋白与高密度脂蛋白胆固醇比值和代谢功能障碍相关脂肪性肝病之间的关联:一项全国代表性研究。
Clin Transl Sci. 2025 Jul;18(7):e70308. doi: 10.1111/cts.70308.
3
Association between oxidative stress and metabolic-associated fatty liver disease in the US population.
美国人群中氧化应激与代谢相关脂肪性肝病之间的关联。
Sci Rep. 2025 Jul 1;15(1):21352. doi: 10.1038/s41598-025-05044-7.
4
Association of behavioral factors, liver function and NAFLD: Bayesian Mendelian randomization.行为因素、肝功能与非酒精性脂肪性肝病的关联:贝叶斯孟德尔随机化
Nutr Metab (Lond). 2025 Jun 23;22(1):63. doi: 10.1186/s12986-025-00961-w.
5
Association between smoking status and non-alcoholic fatty liver disease.吸烟状况与非酒精性脂肪性肝病之间的关联。
PLoS One. 2025 Jun 9;20(6):e0325305. doi: 10.1371/journal.pone.0325305. eCollection 2025.
6
Metabolic Syndrome and Liver Disease: Re-Appraisal of Screening, Diagnosis, and Treatment Through the Paradigm Shift from NAFLD to MASLD.代谢综合征与肝脏疾病:从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病范式转变下的筛查、诊断及治疗再评估
J Clin Med. 2025 Apr 16;14(8):2750. doi: 10.3390/jcm14082750.
7
Liver disorders in substance abusers.药物滥用者的肝脏疾病
Hepatol Forum. 2024 Sep 10;6(1):34-40. doi: 10.14744/hf.2024.2024.0012. eCollection 2025.
8
The relationship between smoking cessation history and significant liver fibrosis among the population with metabolic dysfunction-associated steatotic liver disease in the United States.美国代谢功能障碍相关脂肪性肝病患者中戒烟史与显著肝纤维化之间的关系。
PLoS One. 2025 Apr 1;20(4):e0320573. doi: 10.1371/journal.pone.0320573. eCollection 2025.
9
Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses.吸烟相关的肠道微生物群改变与肥胖及肥胖相关疾病有关:来自两项进行同胞比较分析队列研究的结果。
BMC Med. 2025 Mar 10;23(1):146. doi: 10.1186/s12916-025-03969-4.
10
KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025.2025年韩国肝脏研究学会代谢功能障碍相关脂肪性肝病管理临床实践指南
Clin Mol Hepatol. 2025 Feb;31(Suppl):S1-S31. doi: 10.3350/cmh.2025.0045. Epub 2025 Feb 19.